Wall Street analysts expect Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings per share of $0.18 for the current fiscal quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Allscripts Healthcare Solutions’ earnings. The lowest EPS estimate is $0.17 and the highest is $0.20. Allscripts Healthcare Solutions reported earnings per share of $0.14 in the same quarter last year, which would suggest a positive year over year growth rate of 28.6%. The firm is expected to report its next earnings report after the market closes on Thursday, February 15th.
According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $0.62 per share for the current financial year, with EPS estimates ranging from $0.60 to $0.64. For the next financial year, analysts anticipate that the company will report earnings of $0.76 per share, with EPS estimates ranging from $0.72 to $0.89. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover Allscripts Healthcare Solutions.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, November 2nd. The software maker reported $0.12 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.12. Allscripts Healthcare Solutions had a negative net margin of 12.23% and a positive return on equity of 6.53%.
In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the transaction, the president now owns 1,351,773 shares of the company’s stock, valued at approximately $19,276,282.98. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP James Hewitt sold 36,796 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the completion of the transaction, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The disclosure for this sale can be found here. In the last three months, insiders sold 56,796 shares of company stock valued at $804,842. 0.91% of the stock is owned by insiders.
A number of large investors have recently modified their holdings of MDRX. ETF Managers Group LLC purchased a new position in Allscripts Healthcare Solutions in the 2nd quarter worth about $152,000. Shelton Capital Management purchased a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter valued at about $170,000. Sheaff Brock Investment Advisors LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at about $174,000. Crossmark Global Holdings Inc. purchased a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at about $187,000. Finally, Oakbrook Investments LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the 4th quarter valued at about $194,000.
Shares of Allscripts Healthcare Solutions (MDRX) opened at $15.24 on Monday. Allscripts Healthcare Solutions has a fifty-two week low of $11.01 and a fifty-two week high of $16.13. The company has a market cap of $2,750.00, a price-to-earnings ratio of -13.14, a PEG ratio of 2.15 and a beta of 1.32. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.